Sanofi

Multinational Pharma Share Declines in Indian Drug Market. (Image Source: Freepik)

Pharma MNCs continue to lose India market share

The presence of multinational pharma companies (MNCs) in India’s drug market continues to shrink, reaching 14.5% in May 2025 from…

June 8, 2025 18:27 IST

dividend stocks, stock split, April 2025 corporate actions, CRISIL dividend,

Upcoming dividend announcement, stock split this week: Watch out for these 5 stocks

Watch for dividends, stock splits from CRISIL, Hexaware, Kapil Raj, and more this week. Hold stocks before ex-dates for payouts.

Updated: April 14, 2025 15:04 IST

USFDA approves novel treatment for Hemophilia; Medication can be given up to once every 2 months

Qfitlia does not replace the missing clotting factor. Rather, it reduces the amount of a protein called antithrombin, leading to…

March 30, 2025 11:43 IST

Sanofi to increase competition in atopic dermatitis market after Dupixent’s success

The collaboration between Sanofi and Kymera Therapeutics on SAR444656 may represent a significant opportunity for competition in atopic dermatitis treatment.

January 19, 2025 15:41 IST

Sanofi’s Multiple sclerosis drug misses goal in trials for relapsing disease forms

On Monday, Sanofi only provided a brief summary of the trials, holding off details for a medical conference in Copenhagen…

September 2, 2024 16:28 IST

Sanofi resets footprint in India, Hyd GCC to add new digital competencies

On the investments made, a note shared by the company said, there were plans to invest in all €400 million…

July 17, 2024 17:34 IST

French drugmaker Sanofi to invest over €1 billion in production sites

Sanofi to expand its Global Capacity Centre in Hyderabad

The Hyderabad hub has grown exponentially from being a Medical Hub to now providing several best-in-class services to Sanofi’s global…

July 17, 2024 16:40 IST

Rare diseases, rare diseases in India, Sanofi, Sanofi India, sanofi specialty care, healthcare news, pharma news,

We are moving into newer disease areas; Xenpozyme will be launched in India soon: Anil Raina, GM, Sanofi Specialty Care, India

The French drugmakers have launched groundbreaking medicines for Gaucher disease, Pompe disease, Fabry disease, mucopolysaccharidosis I (MPS I) and acid…

May 30, 2024 16:07 IST

French drugmaker Sanofi to invest over €1 billion in production sites

Sanofi will invest an additional €700 million per year in R&D over the next two years. In 2023, Sanofi invested…

May 14, 2024 10:58 IST

Sanofi launches its anti-diabetic drug in India—Know cost and other key details

According to the company, Soliqua is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting…

May 1, 2024 11:01 IST

Sanofi’s new polio vaccine gets nod in India amid speculations of potential shortage

Sanofi and Serum Institute of India are the leading suppliers of IPV vaccines in India.

April 8, 2024 11:12 IST

French drugmaker Sanofi agrees to settle 4,000 Zantac cancer lawsuits in US state courts

Sanofi now sells Zantac360, a reformulated heartburn medicine whose active ingredient is famotidine.

April 4, 2024 12:38 IST

Sanofi India and Cipla's shares rose today

Sanofi to launch key drugs from its global pipeline in India soon

The company is also looking at widening access through partnerships with companies like Cipla, Dr Reddy’s Laboratories, and Emcure.

April 2, 2024 10:42 IST

Dr Reddy’s to distribute Sanofi’s paediatric and adult vaccine brands in India

The partnership with Sanofi gives Dr. Reddy’s a strong portfolio and major presence in the vaccine segment taking it to…

March 27, 2024 17:59 IST

Sanofi India, Cipla, partnership, distribution, CNS portfolio, anti-epileptic medication, production, manufacturing, healthcare

Sanofi, Cipla enters into exclusive distribution partnership to expand reach of CNS portfolio in India

While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India…

March 27, 2024 09:33 IST

Sanofi, rare disease portfolio, sanofi product portfolio, healthcare news, pharma news,

Sanofi drops rare disease drug purchase after FTC files suit

Sanofi owns the only FDA approved treatments — a biweekly infusion — but Maze is developing a daily oral medication…

December 12, 2023 16:47 IST

Sanofi taps adviser for OTC spinoff as buyout firms circle

The business has also attracted some initial interest from major buyout firms that have been evaluating a potential acquisition

November 16, 2023 15:02 IST

Sanofi spinoff EuroAPI’s shares plunge on sales surprise

Sanofi still owns 30% of EuroAPI and the French state has a 12% stake, reflecting government efforts to bolster national…

October 10, 2023 16:24 IST

Related News

Govt extended ITR AY 2025-26 deadline, but only 4.56 crore returns filed so far

China exits Pakistan’s $60 billion CPEC flagship project; Islamabad turns to ADB for funding

China exits Pakistan’s $60 billion economic corridor project; Islamabad turns to ADB for funding

New Zealand visa application, visa police certificates, visa Regional Passport Office, Indian Ministry of External Affairs, Immigration New Zealand

New Zealand issues new rules for Indian national visa applicants

GST cut backfired? your health insurance premium may go up by up to 5 pc, says report

ICPC 2025: IITs struggle as colleges from Russia, Japan, and China dominate global coding contest

ICPC 2025: IITs struggle as Russia, Japan, and China dominate global coding contest

What does a $1 trillion salary mean – What can it buy and how rich does it make you?

Life1 hr ago

Elon Musk, CEO of Tesla, is expected to become the first trillionaire in the world due to a new pay grade adding 423.7 million shares worth $1 trillion to his paycheck. This would make him wealthier than entire nations and have a major impact on various sectors, global politics, and scientific research. He would also be 100 times richer than the Ambani family.

View all shorts